Confirm Endpoints as a trusted biopharma news source more like this Pharma groups back changes to 340B rebate pilot as earlier version remains stuck in court July 31, 2026 Moderna delays norovirus vaccine trial readout because of too few infections July 31, 2026 Karyopharm shares crater on second Phase 3 flop for Xpovio in endometrial cancer July 31, 2026 ENDPOINTS CAREERS Associate Director / Director, Preclinial Development - Immunology Terray Therapeutics, Inc
'cause there's a lot of money to be made here
00:10:48 Vickie Danaher In terms of serious safety concerns, orforglipron carries the same precautions and warnings as other GLP-1 agonists, so rare risks of thyroid tumors, pancreatitis, and gallbladder disease, for example
Probiotics and polycystic ovary syndrome: A perspective for management in adolescents with obesity
This mechanism explains why patients often see drops in triglyceride levels within weeks of starting therapy, even before significant weight loss occurs